References
Okumura H, Uchikado Y, Omoto I, et al. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases. Ann Surg Oncol. 2014;21:2845–49.
Okumura H, Uchikado Y, Setoyama T, et al. Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy. Surg Today. 2014;44:421–28.
Noda M, Okumura H, Uchikado Y, et al. Correlation between biomarker candidate proteins with the effect of neoadjuvant chemoradiation therapy on esophageal squamous cell carcinoma. Ann Surg Oncol. 2018;25(2):449–55. https://doi.org/10.1245/s10434-017-6271-y.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflicts of interest to disclose.
Additional information
This ASO Author Reflections is a brief invited commentary on the article “Correlation between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma,” Ann Surg Oncol. 2018; 25:449–455.
Rights and permissions
About this article
Cite this article
Okumura, H., Noda, M. & Natsugoe, S. ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 25 (Suppl 3), 715–716 (2018). https://doi.org/10.1245/s10434-018-6837-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6837-3